S&P 500   3,948.72
DOW   32,105.25
QQQ   309.75
Why Wall Street Loves These 3 Penny Stocks
Bank Accounts: Frozen! (Ad)
3 Leading Dividend Stocks Expected To Grow Earnings
Chewy Stock Is Setting Up For Long-Term Profitable Growth 
Bank Accounts: Frozen! (Ad)
Closing prices for crude oil, gold and other commodities
Low Volume Bunge Plunge Presents an Opportunity
Bank Accounts: Frozen! (Ad)
KB Home Strong Results Lift Prices
Carvana May Be Able To Reach Profitability This Year
S&P 500   3,948.72
DOW   32,105.25
QQQ   309.75
Why Wall Street Loves These 3 Penny Stocks
Bank Accounts: Frozen! (Ad)
3 Leading Dividend Stocks Expected To Grow Earnings
Chewy Stock Is Setting Up For Long-Term Profitable Growth 
Bank Accounts: Frozen! (Ad)
Closing prices for crude oil, gold and other commodities
Low Volume Bunge Plunge Presents an Opportunity
Bank Accounts: Frozen! (Ad)
KB Home Strong Results Lift Prices
Carvana May Be Able To Reach Profitability This Year
S&P 500   3,948.72
DOW   32,105.25
QQQ   309.75
Why Wall Street Loves These 3 Penny Stocks
Bank Accounts: Frozen! (Ad)
3 Leading Dividend Stocks Expected To Grow Earnings
Chewy Stock Is Setting Up For Long-Term Profitable Growth 
Bank Accounts: Frozen! (Ad)
Closing prices for crude oil, gold and other commodities
Low Volume Bunge Plunge Presents an Opportunity
Bank Accounts: Frozen! (Ad)
KB Home Strong Results Lift Prices
Carvana May Be Able To Reach Profitability This Year
S&P 500   3,948.72
DOW   32,105.25
QQQ   309.75
Why Wall Street Loves These 3 Penny Stocks
Bank Accounts: Frozen! (Ad)
3 Leading Dividend Stocks Expected To Grow Earnings
Chewy Stock Is Setting Up For Long-Term Profitable Growth 
Bank Accounts: Frozen! (Ad)
Closing prices for crude oil, gold and other commodities
Low Volume Bunge Plunge Presents an Opportunity
Bank Accounts: Frozen! (Ad)
KB Home Strong Results Lift Prices
Carvana May Be Able To Reach Profitability This Year
NASDAQ:TMCI

Treace Medical Concepts - TMCI Insider Trading & Ownership

$24.08
+0.28 (+1.18%)
(As of 03/23/2023 12:00 AM ET)
Add
Compare
Today's Range
$23.91
$24.54
50-Day Range
$20.23
$26.22
52-Week Range
$12.48
$26.50
Volume
214,267 shs
Average Volume
418,069 shs
Market Capitalization
$1.47 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$28.67

Treace Medical Concepts (NASDAQ:TMCI) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
41.89%
Number Of
Insiders Buying
(Last 12 Months)
3
Amount Of
Insider Buying
(Last 12 Months)
$1.66 M
Number Of
Insiders Selling
(Last 12 Months)
11
Amount Of
Insider Selling
(Last 12 Months)
$28.84 M

TMCI Insider Buying and Selling by Quarter

Get TMCI Insider Trade Alerts

Want to know when executives and insiders are buying or selling Treace Medical Concepts stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Treace Medical Concepts Insider Trades History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/15/2023Daniel E OwensInsiderSell6,250$22.87$142,937.5030,914  
3/15/2023Thomas E TimbieDirectorSell50,000$23.03$1,151,500.001,149,069  
3/13/2023F Barry BaysDirectorSell9,400$24.15$227,010.001,272,883  
3/9/2023Aaron BeruttiVPSell733$24.41$17,892.5313,042  
3/9/2023John T TreaceInsiderSell2,075$24.41$50,650.755,539,380  
3/9/2023Mark HairCFOSell1,040$24.41$25,386.4027,110  
3/8/2023Richard W MottDirectorSell45,000$23.17$1,042,650.001,060,000  
2/28/2023James T TreaceDirectorSell37,316$21.54$803,786.64974,125  
2/21/2023F Barry BaysDirectorSell9,400$21.74$204,356.001,291,683  
2/15/2023Sean F ScanlanInsiderSell25,000$21.69$542,250.009,975  
2/15/2023Thomas E TimbieDirectorSell50,000$21.71$1,085,500.001,199,069  
2/7/2023F Barry BaysDirectorSell8,800$23.00$202,400.001,328,814  
2/2/2023Richard W MottDirectorSell4,011$24.00$96,264.001,155,000  
1/30/2023James T TreaceDirectorSell38,071$23.20$883,247.201,023,370  
1/24/2023F Barry BaysDirectorSell25,921$26.03$674,723.631,365,336  
1/17/2023Richard W MottDirectorSell11,014$26.00$286,364.001,250,000  
1/12/2023Richard W MottDirectorSell42,467$26.00$1,104,142.001,267,533  
1/12/2023Sean F ScanlanInsiderSell25,000$25.57$639,250.009,975  
1/9/2023Richard W MottDirectorSell10,444$24.00$250,656.001,310,000  
1/5/2023Richard W MottDirectorSell9,556$24.00$229,344.001,320,444  
12/30/2022Richard W MottDirectorSell75,000$22.67$1,700,250.001,330,000  
12/19/2022F Barry BaysDirectorSell9,067$22.86$207,271.621,490,747  
12/14/2022Thomas E TimbieDirectorSell50,000$24.00$1,200,000.001,299,069  
12/12/2022James T TreaceDirectorSell25,000$24.18$604,500.001,061,441  
12/7/2022F Barry BaysDirectorSell9,061$23.97$217,192.171,509,553  
12/2/2022Daniel E OwensInsiderSell5,625$25.00$140,625.0010,700  
11/30/2022Richard W MottDirectorSell75,000$21.90$1,642,500.001,425,000  
11/28/2022F Barry BaysDirectorSell9,400$22.09$207,646.001,528,014  
11/21/2022Aaron BeruttiVPBuy1,825$21.86$39,894.5013,775  
11/21/2022John T TreaceInsiderBuy15,000$21.83$327,450.005,541,455  
11/21/2022Thomas E TimbieDirectorSell224$22.08$4,945.921,359,139  
11/18/2022Thomas E TimbieDirectorSell39,706$22.70$901,326.201,359,363  
11/17/2022John T TreaceInsiderBuy10,000$21.67$216,700.005,526,455  
11/16/2022Thomas E TimbieDirectorSell50,000$20.14$1,007,000.001,399,069  
11/15/2022Daniel E OwensInsiderSell6,250$20.38$127,375.0010,700  
11/14/2022Sean F ScanlanSVPSell25,000$24.27$606,750.009,975  
11/9/2022F Barry BaysDirectorSell17,123$21.09$361,124.071,546,814  
10/31/2022Richard W MottDirectorSell95,000$23.57$2,239,150.001,500,000  
10/26/2022Scot Michael ElderInsiderSell613$23.46$14,380.9818,862  
10/20/2022James T TreaceDirectorSell8,742$23.02$201,240.841,086,441  
10/18/2022F Barry BaysDirectorSell25,428$24.02$610,780.561,590,199  
10/5/2022F Barry BaysDirectorSell16,274$22.57$367,304.181,629,127  
9/27/2022F Barry BaysDirectorSell14,424$22.36$322,520.641,668,469  
9/13/2022F Barry BaysDirectorSell19,700$22.46$442,462.001,696,729  
8/29/2022F Barry BaysDirectorSell8,064$20.10$162,086.401,720,229  
8/26/2022John T TreaceInsiderBuy21,491$20.95$450,236.455,506,455  
8/23/2022John T TreaceInsiderBuy28,000$18.72$524,160.005,484,455  
8/18/2022James T TreaceDirectorSell34,046$19.09$649,938.141,186,441  
8/16/2022Thomas E TimbieDirectorSell50,000$19.91$995,500.001,449,069  
8/15/2022Daniel E OwensInsiderSell1,500$20.00$30,000.0010,700  
8/5/2022Thomas E TimbieDirectorSell4,904$19.04$93,372.161,499,069  
8/3/2022Thomas E TimbieDirectorSell96,879$18.85$1,826,169.151,552,190  
8/1/2022Daniel E OwensInsiderSell1,000$16.89$16,890.0010,700  
7/18/2022James T TreaceDirectorSell13,961$16.09$224,632.491,256,680  
7/15/2022James T TreaceDirectorSell8,456$16.18$136,818.081,270,641  
7/13/2022James T TreaceDirectorSell4,544$16.13$73,294.721,281,897  
7/5/2022Daniel E OwensInsiderSell1,000$15.00$15,000.0010,700  
6/16/2022James T TreaceDirectorSell20,809$13.58$282,586.221,315,632  
6/1/2022Daniel E OwensInsiderSell1,000$16.67$16,670.0010,700  
5/25/2022James T TreaceDirectorSell30,313$15.35$465,304.551,356,128  
5/18/2022Mark HairCFOBuy6,200$15.80$97,960.0028,150  
5/9/2022Daniel E OwensInsiderSell1,000$15.96$15,960.0010,700  
5/9/2022John R TreaceDirectorSell75,000$14.01$1,050,750.001,822,790  
(Data available from 1/1/2013 forward)












TMCI Insider Trading Activity - Frequently Asked Questions

Who is on Treace Medical Concepts's Insider Roster?

The list of insiders at Treace Medical Concepts includes Aaron Berutti, Daniel E Owens, F Barry Bays, Jaime A Frias, James T Treace, John R Treace, John T Treace, Mark Hair, Richard W Mott, Scot Michael Elder, Sean F Scanlan, Terry W Lubben, and Thomas E Timbie. Learn more on insiders at TMCI.

What percentage of Treace Medical Concepts stock is owned by insiders?

41.89% of Treace Medical Concepts stock is owned by insiders. Learn more on TMCI's insider holdings.

Which Treace Medical Concepts insiders have been buying company stock?

The following insiders have purchased TMCI shares in the last 24 months: Aaron Berutti ($39,894.50), John T Treace ($1,518,546.45), Mark Hair ($267,960.00), and Terry W Lubben ($46,550.00).

How much insider buying is happening at Treace Medical Concepts?

Insiders have purchased a total of 95,016 TMCI shares in the last 24 months for a total of $1,872,950.95 bought.

Which Treace Medical Concepts insiders have been selling company stock?

The following insiders have sold TMCI shares in the last 24 months: Aaron Berutti ($17,892.53), Daniel E Owens ($505,457.50), F Barry Bays ($4,206,877.27), Jaime A Frias ($5,596,910.00), James T Treace ($8,735,118.82), John R Treace ($7,872,000.00), John T Treace ($94,702,484.49), Mark Hair ($25,386.40), Richard W Mott ($8,591,320.00), Scot Michael Elder ($14,380.98), Sean F Scanlan ($3,744,823.60), and Thomas E Timbie ($8,546,599.21).

How much insider selling is happening at Treace Medical Concepts?

Insiders have sold a total of 7,960,264 Treace Medical Concepts shares in the last 24 months for a total of $142,559,250.80 sold.

This page (NASDAQ:TMCI) was last updated on 3/24/2023 by MarketBeat.com Staff